blocker

(redirected from potassium channel blocker)
Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for blocker

References in periodicals archive ?
have entered into a worldwide licensing agreement for Pierre Fabre's selective potassium channel blocker, F17727, the company said.
Opening of potassium channels provides an important alternative mechanism in vasodilation (Nelson and Quayle, 1995) was not involved in vasodilation because administration of potassium channel blockers had no influence on the relaxant activity of TAAC.
Settlement and metamorphosis of the Capitella larvae was, however, stimulated in a concentration-dependent manner by 4-aminopyridine (4-AP), another potassium channel blocker, which blocks outward rectifying potassium currents.
AMPYRA is a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS); this was demonstrated by an improvement in walking speed.
To determine the possible vasorelaxant mechanism exerted by test sample we used cholinergic antagonist, potassium channel blocker and enzymatic inhibitors in endothelium signaling pathways throughout rat aorta ring assay.
A sustained-release formulation of the potassium channel blocker dalfampridine has been approved by the Food and Drug Administration as a treatment to improve walking in people with multiple sclerosis.
RSD1235 is a frequency-dependent sodium and early-activating potassium channel blocker with multiple electrophysiologic effects.
3 [micro]M), respectively; the voltage-gated potassium channel blocker, 4-AP (1 mM); the ATP-sensitive potassium channel blocker, glibenclamide (1 [micro]M); and the inward rectifier potassium channel blocker, [BaCl.
Tedisamil is a nonselective potassium channel blocker with relative atrial selectivity.
Tedisamil is a nonselective potassium channel blocker with relative atrial selectivity Although data from just-completed randomized trials of intravenous tedisamil for acute AF are still being analyzed, there is reason for optimism that this drug causes less QT prolongation and has less possibility of potentially fatal torsades de pointes than current antiarrhythmics.
Full browser ?